Journal Of Clinical Oncology (jco) Podcast
Carboplatin-Gemcitabine-Bevacizumab: Expanding Treatment Options for Recurrent Platinum Sensitive Epithelial Ovarian Cancer
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:29
- Mas informaciones
Informações:
Sinopsis
Carboplatin-Gemcitabine-Bevacizumab represents an additional regimen to consider for management of recurrent platinum sensitive epithelial ovarian cancer, although it raises several questions regarding the role of bevacizumab in this disease setting.
